[go: up one dir, main page]

AR049916A1 - Usos anti-parasitarios de complejos de acido borinico - Google Patents

Usos anti-parasitarios de complejos de acido borinico

Info

Publication number
AR049916A1
AR049916A1 ARP050102417A ARP050102417A AR049916A1 AR 049916 A1 AR049916 A1 AR 049916A1 AR P050102417 A ARP050102417 A AR P050102417A AR P050102417 A ARP050102417 A AR P050102417A AR 049916 A1 AR049916 A1 AR 049916A1
Authority
AR
Argentina
Prior art keywords
parasitary
acid complexes
borinic acid
complexes
parasites
Prior art date
Application number
ARP050102417A
Other languages
English (en)
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of AR049916A1 publication Critical patent/AR049916A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones y métodos de uso de complejos de ácido boronico, especialmente derivados de hidroxiquinolina, imidazol y ácido picolínico como agentes anti-parasitarios y como agentes terapéuticos para el tratamiento de enfermedades causadas por parásitos.
ARP050102417A 2004-06-14 2005-06-13 Usos anti-parasitarios de complejos de acido borinico AR049916A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57947604P 2004-06-14 2004-06-14

Publications (1)

Publication Number Publication Date
AR049916A1 true AR049916A1 (es) 2006-09-13

Family

ID=34979015

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050102417A AR049916A1 (es) 2004-06-14 2005-06-13 Usos anti-parasitarios de complejos de acido borinico

Country Status (9)

Country Link
US (1) US20060014723A1 (es)
EP (1) EP1771182A1 (es)
JP (1) JP2008502702A (es)
AR (1) AR049916A1 (es)
BR (1) BRPI0512025A (es)
CA (1) CA2570534A1 (es)
MX (1) MXPA06014414A (es)
TW (1) TW200610530A (es)
WO (1) WO2005123095A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007257689A1 (en) * 2006-06-12 2007-12-21 Anacor Pharmaceuticals, Inc. Compounds for the treatment of periodontal disease
WO2010018837A2 (ja) * 2008-08-11 2010-02-18 独立行政法人科学技術振興機構 蛋白質架橋阻害剤
CN102227439B (zh) * 2008-10-02 2015-08-19 巴斯夫欧洲公司 络盐
KR101756785B1 (ko) * 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
CN111995634B (zh) * 2020-08-28 2022-08-05 深圳大学 一种四配位有机硼化合物、荧光探针及其制备方法与应用
TR2023001871A1 (tr) * 2023-02-20 2024-08-21 Yedi̇tepe Üni̇versi̇tesi̇ Borun lei̇shmani̇asi̇s hastaliğinin tedavi̇si̇ i̇çi̇n kullanimi
TR2023001878A1 (tr) * 2023-02-20 2024-08-21 Yedi̇tepe Üni̇versi̇tesi̇ Borun nöronal kaynakli lei̇shmani̇asi̇s hastaliğinin tedavi̇si̇ i̇çi̇n kullanimi

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348947A (en) * 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US5348948A (en) * 1993-05-07 1994-09-20 American Cyanamid Company 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
US5574017A (en) * 1994-07-05 1996-11-12 Gutheil; William G. Antibacterial agents
WO2000044387A1 (fr) * 1999-01-29 2000-08-03 Nitto Kasei Co., Ltd. Composes organobores presentant une activite de coccidiostats
DE10110051C2 (de) * 2001-03-02 2003-07-03 Clariant Gmbh Verfahren zur Herstellung von Boron- und Borinsäuren
US7390806B2 (en) * 2002-12-18 2008-06-24 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use
US20040224923A1 (en) * 2002-12-18 2004-11-11 Ving Lee Antibiotics containing borinic acid complexes and methods of use

Also Published As

Publication number Publication date
MXPA06014414A (es) 2007-03-08
TW200610530A (en) 2006-04-01
CA2570534A1 (en) 2005-12-29
BRPI0512025A (pt) 2008-02-06
WO2005123095A1 (en) 2005-12-29
JP2008502702A (ja) 2008-01-31
EP1771182A1 (en) 2007-04-11
US20060014723A1 (en) 2006-01-19

Similar Documents

Publication Publication Date Title
BRPI0512108A (pt) antibióticos contendo complexos de ácido borìnico e métodos de uso
CO6351786A2 (es) Inkibidores de la cinasa map p38
CR20110230A (es) Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38
CR10358A (es) Pirido[3,2-e] pirazinas, su uso como inhibidores de fosfodiesterasa 10, y procesos para prepararlos
ECSP11011113A (es) Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades
MXPA05006685A (es) Antibioticos que contienen complejos de acido borinico y metodos de uso.
BRPI0615270A2 (pt) pirazol fundido como inibidores de p38 map cinase
NO20070782L (no) Tetrapeptidanaloger.
DOP2010000390A (es) Compuestos de piridina
MX2010010505A (es) Imidazoquinolinas y derivados de pirimidina como moduladores potentes de los procesos angiogenicos impulsados por el factor de crecimiento endotelial vascular (vegf).
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
MY180894A (en) Methods for incresing efficacy of folr1 cancer therapy
UA98449C2 (en) Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
CY1110084T1 (el) Χρηση συμπυκνωμενων ετεροκυκλικων ενωσεων ως αναστολεις scce για την θεραπευτικη αγωγη δερματικων ασθενειων
EA200800564A1 (ru) Производные ксантина как селективные агонисты нм74а
MX2009005622A (es) Dihidro-imidazoles sustituidos y su uso en el tratamiento de tumores.
MX2009006567A (es) Pirimidinilpirazoles como principios activos insecticidas y parasiticidas.
UY28271A1 (es) Compuestos químicos
TW200612966A (en) Boron-containing compounds and methods of use
BRPI0512049A (pt) usos antivirais de complexos de ácido borìnico
UY28366A1 (es) Compuestos químicos
AR049916A1 (es) Usos anti-parasitarios de complejos de acido borinico
WO2007125383A3 (en) Topical drug delivery by iontophoresis
HN2006007774A (es) Imidazoles sustituidos con heterociclilamida
EA200800562A1 (ru) Производные имидазопиридина в качестве лигандов каннабиноидного рецептора

Legal Events

Date Code Title Description
FB Suspension of granting procedure